New industry data covering the first six months of 2026 shows that Chinese manufacturers accounted for more than 97 percent of all humanoid robot shipments worldwide. The figures, released by market research firm Smart Analytics Global (SAG), also indicate that China represented over 85 percent of global demand for these machines during the same period.
Total global humanoid robot shipments reached approximately 19,100 units in the first half of the year, a year-on-year increase of 272 percent. The market leadership position also changed hands during this period. AGIBOT, a Chinese robotics company, overtook Unitree Robotics to become the world's largest humanoid robot vendor by shipment volume.
Unitree Robotics, which had been the global leader in 2025 with annual shipments of 5,500 units, moved forward with its initial public offering (IPO) on Shanghai's stock market. The company set its offering price at 150.8 yuan (approximately $22.35) per share. Media reports estimate the IPO is expected to raise 6.1 billion yuan, implying a market capitalization of around 61 billion yuan. Unitree announced that the final online subscription winning rate would be 0.0181 percent. This listing makes Unitree the first humanoid robot A-share stock.
Two other landmarks accompanied these shipment figures. On the same Monday that the data was released, China's industrial upgrade agenda saw progress in what analysts describe as the "new new three" strategic sectors: robotics, artificial intelligence, and innovative medicine. The term itself signals a shift from earlier categories. China's export structure has moved through what observers call the "old three" (garments, furniture, home appliances) and the "new three" (new energy vehicles), and now into this third phase.
Industry analysts point to several factors behind the rapid scale-up. Zhang Xiaorong, director of the Beijing-based Cutting-Edge Technology Research Institute, told the Global Times that the answer lies not in policy slogans alone but in synergies rooted in China's manufacturing base, early institutional frameworks, and vast application scenarios. These elements, he said, have driven the "new new three" industries onto the global stage.
Supply chain localization has been a decisive factor. A Shenzhen-based robot company executive told CCTV News that more than 90 percent of key parts for its humanoid robots are sourced domestically. Institutional analysis cited in the source material notes that Unitree Robotics' supply chain domestic production rate reaches 90 percent, with all core components fully self-developed. The same executive said no other market is better suited for the robotic industry than China.
The large domestic market functions as a unique testing ground, according to Zhang. Strong robot exports reflect advances in complete machine design, system integration, scenario algorithms, rapid delivery, and cost control. These advances accompany continued localization of reducers, servo systems, and sensors. Large-scale applications in new energy vehicles, electronics manufacturing, and warehousing provide frequent iteration and engineering validation.
Institutional foresight also played a role in the sector's development. Robot manufacturing was first listed as an independent industry in China's national standard for industry classification in October 2017. Sub-categories including "industrial robot manufacturing" and "special operation robot manufacturing" followed in 2023. Analysts noted that this early classification facilitated later policy support, capital-market positioning, and statistical monitoring.
Policy support has continued into 2026. In June, several ministries launched a special program for real-scenario training of humanoid robots and embodied AI. Customs adjustments effective from January 1 added specific tariff codes for intelligent biomimetic and cleaning robots, simplifying export clearance. Insurance coverage has also followed. In June, China Export & Credit Insurance Corp issued an insurance policy for AGIBOT's embodied robot export project, providing overseas risk coverage.
Official data cited in the source material shows China has more than 400 complete humanoid robot models, over half the global total. Quadruped robots account for nearly 70 percent of worldwide sales. Yang Delong, chief economist at Shenzhen-based First Seafront Fund, told the Global Times that China may produce more than 100,000 humanoid robots this year, with even higher growth expected in subsequent years.
Export momentum has reached new heights. After becoming a net exporter of industrial robots for the first time in 2025, China's industrial robot exports reached 6.29 billion yuan in the first half of 2026, reaching 141 countries and regions. Surgical robot exports rose 3.3 times year-on-year. Overall robot exports grew 359 percent.
AGIBOT illustrated the rapid scaling. Its 15,000th embodied AI robot rolled off the line on June 28, less than three months after the 10,000-unit milestone. All units are being delivered to domestic and overseas customers for use in 3C (computer, communication and consumer electronics) manufacturing, warehousing and logistics, and commercial services. Jiang Qingsong, company partner and co-president of AGIBOT, said the company aims for overseas sales to exceed 30 percent of its total in 2026 and potentially surpass 50 percent later.
The robotics surge is closely backed by China's AI sector. Hugging Face's latest report found that over the past year, Chinese models quickly accounted for the plurality or 41 percent of downloads, surpassing the US for the first time. On the OpenRouter platform, Chinese AI models' token usage reached 34.25 trillion in the week ended Sunday, roughly half of global share, while remaining ahead of US models for the 15th consecutive week.
Yang noted that China's AI progress is supporting growth across six frontier sectors: robotics, semiconductors, computing power and algorithms, commercial spaceflight, solid-state batteries, and biomedicine. In innovative drugs, by the end of 2025 China had 4,751 innovative drugs in development, 33.7 percent of the world total, making it the global leader in the pipeline. Outbound licensing deals totaled about $110 billion in the first half of 2026, already 80 percent of the full-year 2025 figure, with Chinese firms occupying eight of the global top 10 pharma deals. During the same period, 38 innovative drugs were approved, according to data from the National Medical Products Administration.
Why it matters for European robot service
European buyers, system integrators, and service providers should pay close attention to these developments for several reasons, even though the data concerns Chinese domestic production and export figures.
First, the concentration of manufacturing capacity matters for supply chain resilience. When more than 97 percent of global humanoid robot shipments come from a single country's vendors, European operators who depend on these machines must consider their exposure to that concentration. The source material does not disclose which specific European countries or companies are importing these robots, nor does it break down shipment destinations. What is known is that China's industrial robot exports reached 141 countries and regions in the first half of 2026, and the source does not specify which of those are European.
Second, the pace of scale-up has implications for pricing and availability. The 272 percent year-on-year growth in global humanoid robot shipments suggests a market moving from early adoption toward broader deployment. European operators who have been evaluating humanoid robots for warehouse, logistics, or manufacturing applications may find that the competitive landscape is shifting. The source material does not provide pricing data for AGIBOT or other vendors, so it is not possible to state whether prices are falling or rising.
Third, the localization of supply chains within China raises questions about after-sales service and spare parts availability in Europe. The source material states that more than 90 percent of key parts for one Shenzhen-based company's humanoid robots are sourced domestically, and that Unitree's supply chain domestic production rate reaches 90 percent. This means that European service providers may need to consider how spare parts will be sourced, what lead times might be, and whether local service capabilities will be developed. The source material does not disclose any information about European service networks, spare-part lead times, or response times for these vendors. Those details remain unknown.
Fourth, the insurance policy issued for AGIBOT's embodied robot export project signals that export risk coverage is being formalized. This could affect how European buyers structure their procurement contracts and risk management. The source does not specify which countries or regions the insurance policy covers, nor does it disclose the policy terms.
Fifth, the rise of China's AI sector, with Chinese models accounting for 41 percent of downloads on Hugging Face and roughly half of token usage on OpenRouter, suggests that the software layer of robot services may increasingly rely on Chinese AI infrastructure. European operators should be aware that the algorithms powering their humanoid robots may be trained on or served by Chinese AI models. The source material does not disclose which AI models are used in specific robot products, so this remains a general observation.
For European robot service providers, the competitive pressure is real. Chinese vendors are scaling production rapidly, with AGIBOT reaching 15,000 units in less than three months after its 10,000-unit milestone. This scale brings cost advantages that European manufacturers may find difficult to match. However, the source material does not provide cost comparisons or pricing data, so any claims about cost competitiveness would be speculative.
The source material also notes that China has more than 400 complete humanoid robot models, over half the global total. This variety means European buyers have many options to evaluate. It also means that European service providers may need to develop expertise across a wider range of platforms than previously necessary.
What buyers and operators should know
For European buyers and operators considering humanoid robots, several practical points emerge from the source material.
First, market leadership has shifted. AGIBOT is now the world's largest humanoid robot vendor by shipments, having overtaken Unitree. Buyers who had been evaluating Unitree should also consider AGIBOT and other Chinese vendors. The source does not provide a complete list of vendors or their market shares beyond the top two.
Second, delivery capacity is scaling rapidly. AGIBOT's 15,000th unit rolled off the line on June 28, less than three months after the 10,000-unit milestone. This suggests that production bottlenecks are being resolved. However, the source does not disclose current lead times for new orders, so buyers should not assume immediate availability.
Third, use cases are expanding. The source material indicates that AGIBOT's units are being delivered for use in 3C manufacturing, warehousing and logistics, and commercial services. These are the same application areas that European operators are exploring. The source does not provide specific performance data, payload capacities, or operational metrics for these robots.
Fourth, export orientation is increasing. AGIBOT aims for overseas sales to exceed 30 percent of its total in 2026 and potentially surpass 50 percent later. This suggests that European buyers may find increasing availability of these robots in their markets. The source does not disclose which overseas markets are being targeted or whether Europe is a priority.
Fifth, supply chain localization means that replacement parts may need to come from China. The source states that more than 90 percent of key parts for one company's robots are sourced domestically, and Unitree's domestic production rate is 90 percent. Buyers should clarify with vendors whether European spare parts inventories will be established. The source does not disclose any information about spare-part lead times or European service centers.
Sixth, the IPO of Unitree on Shanghai's stock market may affect the company's financial stability and long-term commitment to the market. The estimated market capitalization of around 61 billion yuan suggests significant investor interest. The source does not disclose how the IPO proceeds will be used.
Seventh, policy support is ongoing. The special program for real-scenario training of humanoid robots and embodied AI launched in June 2026, and customs adjustments have simplified export clearance. These measures may continue to accelerate production and export volumes. The source does not disclose the program's budget or duration.
Eighth, buyers should verify current shipment data independently. The source material cites Smart Analytics Global (SAG) as the research firm behind the 97 percent figure and the 19,100-unit shipment estimate. The source does not disclose SAG's methodology or whether other research firms have produced different estimates.
Ninth, the source material does not disclose pricing for humanoid robots from AGIBOT, Unitree, or other vendors. Buyers should request current quotations directly from vendors. The source also does not disclose total cost of ownership, maintenance costs, or energy consumption figures.
Tenth, the source material does not disclose any safety certifications, regulatory approvals, or compliance standards for these robots in European markets. Buyers should verify that any robot they purchase meets applicable European regulations before deployment.
Finally, buyers should note that the source material does not disclose any information about software updates, cybersecurity features, or data handling practices for these robots. Given that Chinese AI models account for a significant share of global downloads and token usage, buyers should clarify with vendors where data is processed and stored.
The source material also does not disclose any information about training requirements, operator certification, or safety incident rates for these robots. These factors should be part of any procurement evaluation.
In summary, the data shows a rapidly scaling Chinese humanoid robot industry with strong domestic supply chains and increasing export ambitions. European buyers have more options than ever, but should conduct thorough due diligence on service support, spare parts availability, and regulatory compliance before making purchasing decisions. The source material provides shipment figures and production milestones, but leaves many operational details undisclosed.
Sources
https://www.globaltimes.cn/page/202608/1367923.shtml
Published by Vigla Media OÜ (Estonia).